Skip to main content

Filtration and Analysis of Circulating Cancer Associated Cells from the Blood of Cancer Patients

  • Protocol
  • First Online:
Book cover Biosensors and Biodetection

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1572))

Abstract

Filtration is one of the most efficient methods to remove red and white blood cells from whole blood, while retaining larger cells on the surface of the filter. Precision pore microfilters, such as the CellSieve™ microfilters, are ideally suited for this purpose, as they are strong, with uniform pore size and distribution, and have low fluorescent background required for microscopic image analysis. We present a system to implement the filtration of whole blood in combination with CellSieve™ microfilters that is simple and straightforward to use. Being that the blood of cancer patients often contains both tumor cells and stromal cells associated with cancer that are larger than normal blood cells, microfiltration shows great promise in better understanding these cell types. Accurate identification and characterization of cancer associated cells has led to increased specificity as it relates to CTCs and epithelial–mesenchymal transition cells (EMTs) and enabled the identification of previously unknown cell types, such as cancer associated macrophage-like cells (CAMLs). Using a system that isolates both CTCs and circulating stromal cells, clinicians can better diagnose cancer patients to determine therapy, monitor treatment, and watch for recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf

  2. WHO. http://www.who.int/mediacentre/factsheets/fs297/en/

  3. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897–6904

    Article  Google Scholar 

  4. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF (2004) Circulating tumor cells, disease progression and survival in metastatic breast cancer. N Engl J Med 351:781–791

    Article  CAS  Google Scholar 

  5. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14:6302

    Article  Google Scholar 

  6. Cohen SJ, Alpaugh RK, Gross S, O’Hara SM, Smirnov DA, Terstappen LW, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ (2006) Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 6:125–132

    Article  CAS  Google Scholar 

  7. Seal SH (1965) A sieve for the isolation of cancer cells and other large cells from the blood. Cancer 17:637–642

    Article  Google Scholar 

  8. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacou RB, Bréchot C, Paterlini-Bréchot P (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156:57–63

    Article  CAS  Google Scholar 

  9. Zheng S, Lin H, Liu J-Q, Balic M, Datar R, Cote RJ, Tai Y-C (2007) Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatograph A 1162:154–161

    Article  CAS  Google Scholar 

  10. Lin, HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI, Fleisher M, Stadler W, Datar RH, Tai YC, Cote RJ (2010) Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 16:5011–5018

    Google Scholar 

  11. Harouaka RA, Zhou MD, Yeh YT, Khan WJ, Das A, Liu X, Christ CC, Dicker DT, Baney TS, Kaifi JT, Belani CP, Truica CI, El-Deiry WS, Allerton JP, Zheng SY (2014) Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells. Clinical Chemistry 60:323–333

    Google Scholar 

  12. Adams DL, Zhu P, Makarova O, Martin S, Charpentier M, Chumsri S, Li S, Amstutz P, Tang CM (2014) The systematic study of circulating tumor cell isolation using lithographic microfilters. RSC Adv 4:4334–4342

    Article  CAS  Google Scholar 

  13. Adams DL, Stefansson S, Haudenschild S, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Tang CM, Alpaugh RK (2015) Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch® CTC test. Cytometry A 87(2):137–144

    Article  Google Scholar 

  14. Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC, Ogden IM, Catalona W, Chumsri S, Tang CM, Cristofanilli M (2014) Circulating giant macrophages as a potential biomarker of solid tumors. Proc Natl Acad Sci U S A 11(9):3514–3519

    Article  Google Scholar 

  15. Adams DL, Alpaugh RK, Martin SS, Charpentier M, Chumsri S, Cristofanilli M, Adams DK, Makarova OV, Zhu P, Li S, Tang C-M, Stefansson S (2016) Precision microfilters as an all in one system for multiplex analysis of circulating tumor cells. RSC Adv 6:6405–6414

    Article  CAS  Google Scholar 

  16. FDA granted pre-market approval to Dako North America, Inc., an Agilent Technologies company, for the PD-L1 IHC 22C3 PharmDx test for the drug Keytruda® (Merck) for the treatment of non-small cell lung cancer (October 2, 2015)

    Google Scholar 

  17. FDA approved the Dako North America, Inc., an Agilent Technologies company, for PD-L1 IHC 28–8 PharmDx test for the drug Opdivo® (Bristol-Myers Squibb) as a complementary diagnostic for non-squamous non-small cell carcinoma. (October 9, 2015)

    Google Scholar 

Download references

Acknowledgments

This research is funded by the U.S. Army Research Office (ARO) and the Defense Advanced Research Projects Agency (DARPA) (W911NF-14-C-0098). The content of the information does not necessarily reflect the position or the policy of the US Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cha-Mei Tang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Tang, CM., Zhu, P., Li, S., Makarova, O.V., Amstutz, P.T., Adams, D.L. (2017). Filtration and Analysis of Circulating Cancer Associated Cells from the Blood of Cancer Patients. In: Prickril, B., Rasooly, A. (eds) Biosensors and Biodetection. Methods in Molecular Biology, vol 1572. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6911-1_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6911-1_32

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6910-4

  • Online ISBN: 978-1-4939-6911-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics